FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.
about
An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatmentTreatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patientsInternal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic LeMobilization of CD34+ progenitor cells in association with decreased proliferation in the bone marrow of macaques after administration of the Fms-like tyrosine kinase 3 ligand.Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupClinical and proteomic characterization of acute myeloid leukemia with mutated RAS.Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centrePrognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARAAcute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid eraResults of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemiaFLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology GroupMolecular characteristics and chromatin texture features in acute promyelocytic leukemia.Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutationsAdverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status.The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia.Early mortality in acute promyelocytic leukemia: Potential predictors.
P2860
Q27027207-C4275DCA-B6F9-4BD0-B93C-58AD6E47BBB0Q27851636-B0ABB7CE-9EEC-4567-833E-00C357EC508BQ27853031-BAD5AE09-214F-4D6B-AFCF-F9935DF7347CQ34044928-277624B9-437E-4AF4-BD67-EEBF587B5411Q34541742-06BB116F-9C44-4CDA-8CA9-A4BC84F8E292Q34638143-EB4F76C4-BFBE-4B37-90BA-DE91AB0D71C2Q34754867-42EFB079-362D-4240-A0A6-48E358CAD439Q34953881-665FD752-A188-405A-A3F0-0F5503C24ED9Q35265901-23354925-D601-487C-8949-FCCB5628E8B1Q35596919-C2120AE2-41D2-4ECB-B580-BE1E0B2297AAQ35640734-498C33E1-E1C6-4D6D-B23D-5B7ECEA7FBEDQ35717816-9A25D072-D8CF-403E-9530-EA270ADAB484Q36012998-968026B5-5ABA-432A-A02F-D0378A2319E9Q36338616-B2B6337A-6AFE-440C-9787-B81B2396347EQ36410195-BEB8A339-7C93-42FC-AEF9-AFEC1865274EQ36497421-965E1A23-E384-4245-A151-4378624B218BQ36734284-6D71E963-DD91-4ECB-B938-75D63E293E25Q37212864-F6D04E23-591B-42AC-9491-D9116ECFF11CQ40269702-118065CF-8B48-4D17-8791-B7DDC72B3128Q42982146-4B63EA8A-7627-4DB3-97E1-9EB1E0DAAB23Q46790741-B89DB4C3-307C-4FBD-92C4-D168CA4FAAE9Q47292792-FCAACA5C-155D-455C-8FBE-DEBA8EBB1E15Q52355167-4689B2EB-11FC-47F3-8E62-5453F21EAF55
P2860
FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@en
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@nl
type
label
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@en
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@nl
prefLabel
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@en
FLT-3 aberrations in acute pro ...... iations and prognostic impact.
@nl
P2093
P2860
P1476
FLT-3 aberrations in acute pro ...... ciations and prognostic impact
@en
P2093
Albert K Lie
Alvin Fung
Cheuk H Chan
Edmond S K Ma
Kit F Wong
Raymond Liang
Yok L Kwong
P2860
P304
P356
10.1111/J.1365-2141.2004.04935.X
P407
P50
P577
2004-05-01T00:00:00Z